Walleye Capital’s Surgery Partners SGRY Stock Holding History

Walleye Capital’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124K	Sell	7,400 -5,900	-44%	-$82.8K	﹤0.01%	3767
2026 Q1	$159K	Buy	13,300 +8,700	+189%	+$125K	﹤0.01%	3459
2025 Q4	$71.1K	Sell	4,600 -20,000	-81%	-$368K	﹤0.01%	3987
2025 Q3	$532K	Buy	+24,600	New	+$549K	﹤0.01%	2556
2025 Q1	–	Sell	-18,600	Closed	-$394K	–	5042
2024 Q4	$394K	Hold	18,600	–	–	﹤0.01%	3190
2024 Q3	$600K	Sell	18,600 -3,200	-15%	-$94.5K	﹤0.01%	3125
2024 Q2	$519K	Buy	21,800 +18,900	+652%	+$485K	﹤0.01%	3484
2024 Q1	$86.5K	Buy	+2,900	New	+$90.7K	﹤0.01%	4463

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KSCM

King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Walleye Capital's SGRY Position: Q2 2026 in Review

Walleye Capital increased its Surgery Partners (SGRY) stake by 12% in Q2 2026, buying an estimated $5.15K and bringing the position to 3,529 shares worth $59.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4121.

Walleye Capital first reported a position in SGRY in Q3 2021 and has held it in 13 quarters since. The position peaked at $16.1M in Q3 2024. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

Walleye Capital held 3,529 shares of Surgery Partners worth $59.3K as of Q2 2026.
Walleye Capital bought 367 Surgery Partners shares in Q2 2026, an estimated $5.15K.
Surgery Partners made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4121 holding.
Walleye Capital first reported a position in Surgery Partners in Q3 2021 and has held it in 13 quarters since.
Walleye Capital's Surgery Partners position peaked at $16.1M in Q3 2024.
187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.